Search research articles
Contact Us
Filters
Showing results (91-100 of 184) with videos related to
Page
of 19
Sort By:
Cancer Research
|
October 7, 2010
Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma
Christopher Traenka, Marc Remke, Andrey Korshunov, et al.
BMC Cancer
|
February 18, 2016
MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties
Sebastian Dietl, Stefanie Schwinn, Susanne Dietl, et al.
Cancer Research
|
November 23, 2021
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Wei Liu, Paweł Stachura, Haifeng C Xu, et al.
Oncotarget
|
January 11, 2015
A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma
Fengfei Wang, Marc Remke, Kruttika Bhat, et al.
The Journal of Clinical Investigation
|
April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister, Wibke G Janzarik, Marc Remke, et al.
Journal of Neuro-Oncology
|
July 10, 2024
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, et al.
Cancer Discovery
|
August 8, 2014
ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents
Sameer Agnihotri, Kelly Burrell, Pawel Buczkowicz, et al.
Molecular Cancer Therapeutics
|
May 27, 2020
A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma Cells
Diren Usta, Romain Sigaud, Juliane L Buhl, et al.
Acta Neuropathologica Communications
|
April 5, 2020
KLF4<sup>K409Q</sup>-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment
Niklas von Spreckelsen, Natalie Waldt, Rebecca Poetschke, et al.
Cancer Research
|
June 22, 2016
PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma
Sameer Agnihotri, Brian Golbourn, Xi Huang, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 184) with videos related to
Sort By:
Page
of 19
Cancer Research
|
October 7, 2010
Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma
Christopher Traenka, Marc Remke, Andrey Korshunov, et al.
BMC Cancer
|
February 18, 2016
MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties
Sebastian Dietl, Stefanie Schwinn, Susanne Dietl, et al.
Cancer Research
|
November 23, 2021
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Wei Liu, Paweł Stachura, Haifeng C Xu, et al.
Oncotarget
|
January 11, 2015
A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma
Fengfei Wang, Marc Remke, Kruttika Bhat, et al.
The Journal of Clinical Investigation
|
April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister, Wibke G Janzarik, Marc Remke, et al.
Journal of Neuro-Oncology
|
July 10, 2024
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases
Sebastian Jeising, Ann-Christin Nickel, Johanna Trübel, et al.
Cancer Discovery
|
August 8, 2014
ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents
Sameer Agnihotri, Kelly Burrell, Pawel Buczkowicz, et al.
Molecular Cancer Therapeutics
|
May 27, 2020
A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma Cells
Diren Usta, Romain Sigaud, Juliane L Buhl, et al.
Acta Neuropathologica Communications
|
April 5, 2020
KLF4<sup>K409Q</sup>-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment
Niklas von Spreckelsen, Natalie Waldt, Rebecca Poetschke, et al.
Cancer Research
|
June 22, 2016
PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma
Sameer Agnihotri, Brian Golbourn, Xi Huang, et al.
Page
of 19